Skip to main content
Raphas Co., Ltd. logo

Raphas Co., Ltd. — Investor Relations & Filings

Ticker · 214260 ISIN · KR7214260002 KO Manufacturing
Open in API
Filings indexed 325 across all filing types
Latest filing 2021-11-19 Major Shareholding Noti…
Country KR South Korea
Listing KO 214260

About Raphas Co., Ltd.

https://www.raphas.com/

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including acquisition methods and collateral agreements. This falls under the 'Major Shareholding Notification' category.
2021-11-19 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 라파스' (Raphas Co., Ltd.) covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, business operations, management discussions, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This is a standard regulatory filing in South Korea used by corporate insiders (directors/executives) to disclose their personal share transactions and holdings. According to the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2021-11-01 Korean
투자판단관련주요경영사항(알레르기비염 면역치료제 DF19001의 임상 1상 임상시험계획승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from a Korean company (Raphas) regarding the approval of a Phase 1 clinical trial for a new drug (DF19001). It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market, which are used to disclose material events such as clinical trial approvals. Since this is a specific regulatory announcement of a material event and does not fit into categories like financial reports, dividends, or governance, it is classified as a Regulatory Filing (RNS).
2021-10-19 Korean
소송등의제기ㆍ신청(경영권분쟁소송)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding ('소송 등의 제기ㆍ신청') specifically concerning a management dispute and a request for an extraordinary general meeting ('임시주주총회소집허가'). It details the case name, the parties involved, the court, and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR) as it pertains to significant legal actions involving the company.
2021-10-18 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location (online), purpose, and agenda items for the presentation. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2021-10-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.